Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas:  Lung Cancer Mutation Consortium (LCMC 2.0).

Authors

Mark Kris

Mark G. Kris

Memorial Sloan Kettering Cancer Center, New York, NY

Mark G. Kris , Bruce E. Johnson , David J. Kwiatkowski , Ignacio Ivan Wistuba , Lynne D Berry , Eric B. Haura , Mark A. Socinski , Suresh S. Ramalingam , Bonnie S. Glisson , Saiama Naheed Waqar , Gregory Alan Otterson , Joan H. Schiller , Edward B. Garon , Jeremy Paul Cetnar , Katerina A Politi , Julie R. Brahmer , Lecia V. Sequist , Christine Marie Lovly , Kelly Kugler , Paul A. Bunn Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01014286

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8094)

DOI

10.1200/jco.2015.33.15_suppl.8094

Abstract #

8094

Poster Bd #

418

Abstract Disclosures

Similar Posters

First Author: Juliana Eng

Poster

2014 ASCO Annual Meeting

Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.

Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.

First Author: Lindsay Carol Overton

Poster

2013 ASCO Annual Meeting

Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.

Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.

First Author: Takehito Shukuya